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Collagen-induced arthritis (CIA) is an inflammatory arthropathy induced by im-
munizing rodents with type II collagen, a major protein ofhyaline cartilage (1). CIA
is characterized by proliferative synovitis that erodes the adjacent cartilage, ultimately
producing joint destruction and ankylosis (2). It shares important clinical, histolog-
ical, genetic, and immunologic features with human rheumatoid arthritis (RA) (3).
However, there are significant differences between CIA and RA and the relevancy
of CIA to human arthritis has been debated (4). Among the limitations of CIA as
a model was that it could be induced only in rodents and not in other commonly
used laboratory animals, including guinea pigs and rabbits. However, it was recently
reported that squirrel monkeys are also susceptible to CIA (5). This means that CIA
is not a disease peculiar to certain rodents but can also be induced in primates. We
report here that rhesus and cynomolgus monkeys also develop polyarthritis after
immunization with type 11 collagen.
Animals.
￿
Three adult cynomolgus monkeys, Macacafascicularis, weighing 5-7 kg, and five
rhesus monkeys, Macaca mulatta, were used in this study. All monkeys were female except
monkey number 88 who was a castrated male monkey. They were housed individually, fed
a commercial monkey diet supplemented with fresh fruits, and maintained in a 12-h light/12-
h dark cycle. Room air temperature was kept at 72 t 2'F and at 50 ± 20% relative humidity.
Air was not recirculated and was exchanged 12-15 times each hour.
Antigens.
￿
Native type II and type I collagens were prepared from fetal bovine cartilage
and skin, respectively, as previously described (1). Collagen fragments were prepared by cy-
anogen bromide digestion of constituent a chains and purification of the resulting peptides.
Each peptide was renatured to its native triple helical conformation by stepwise cooling as
previously described in detail (6).
Immunizations.
￿
Native collagen was dissolved in 0 .1 N acetic acid at a concentration of
2 mg/ml by stirring overnight at 4°C. The collagen solution was then emulsified with Freund's
adjuvant using an homogenizer (VirTis Co., Inc., Gardiner, NY). Two cynomolgus monkeys
were each immunized intramuscularly in the posterior thigh with 1 mg of native type II col-
lagen in CFA. Booster immunizations were given with 1 mg of collagen emulsified in IFA
at intervals as shown in Fig. 1. An unimmunized monkey of the same species served as a control.
Three rhesus monkeys were also immunized with 2 mg of type II collagen in CFA and
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boosted with 1 mg in IFA at monthly intervals for 2 mo. A final booster was given after 5
mo. Two monkeys of the same species were used as controls: one was immunized with type
I collagen and another was not immunized.
Clinical Observations.
￿
The monkeys were observed regularly for signs of arthritis. Their
weights were recorded and blood was obtained for hemograms, antibody determination, and
erythrocyte sedimentation rate. The presence of arthritis was confirmed by radiological ex-
amination.
Measurement ofAntibody Levels.
￿
Serum antibody titers were measured by modification of
an ELISA described previously (7). ELISA-plates were coated with intact collagen or cy-
anogen bromide-derived peptides 8, 10, 11, and 12 at a concentration of 5 wg/ml. Assay tem-
perature was maintained at 4°C to prevent denaturation of the renatured peptides. Sera for
analysis were diluted in 0.15 M NaCl, 0.1 M Tris-HCI, pH 7.4, containing 0.05% Tween
20 (PBSTween) and were incubated in the ELISA plates overnight. The plates were washed
with PBSTween and incubated with peroxidase-conjugated goat anti-monkey IgG. Plates
were again washed and developed with orthophenylenediamine dissolved in citrate-phosphate
buffer, pH 5.5, containing H202 . After 1 h the absorbance of each well was measured at 490
nm using an automated reader (model 580; Dynatech Laboratories, Inc., Alexandria, VA).
Histology.
￿
Specimens for histologic examination were fixed in cold 95% ethanol, decalcified
in cold 5% ethylene diamine tetruacetic acid solution, pH 7.4, and prepared for staining
using the technique described by Sainte-Marie (8). Sections were cut at 7 gm and stained
by hematoxylin and eosin.
Results
Clinical Observations.
￿
The earliest change noted after immunization was anorexia
developing as early as 10 d after primary immunization. All three rhesus monkeys
lost weight by day 59 while the control monkeys had a moderate gain (Fig. 1). Anorexia
in some monkeys was severe enough to warrant daily feeding by stomach tube. All
of the type II collagen-immunized monkeys developed arthritis. The interphalan-
gealjoints and wrists became swollen and warm to the touch. Some joints exhibited
distinct fine crepitation. The presence of arthritis was confirmed by radiography (Fig.
2). The arthritis in the wrists persisted and resulted in marked limitation of motion
(Fig. 3). Acute episodes of arthritis and anorexia tended to occur -10-14 d after
booster and lasted for 2 wk. Monkeys lost between 32 and 43 % oftheir body weight
before recovery began. The ability of a booster immunization to cause a flair of ar-
thritis was variable. During the acute episodes monkeys became depressed and less
mobile. Erythrocyte sedimentation rates were elevated (32-52 mm). Two monkeys
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FIGURE 1.
￿
Body weights ofex-
perimental animals monkey No.
1122 (o); monkey No. 411 (O);
monkey No. 419 (0). These
monkeys were immunized with
type II collagen; monkey no. 416
(/) was not immunized; mon-
key 88 (A) was immunized with
type I collagen; Monkeys were
initially immunized with 1 mg
oftype II collagen in CFA adju-
vant. Booster (t) were given us-
ing 1 mg collagen in IFA. Ex-
periment on monkey no. 419 was
2°°
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FIGURE 2 .
￿
Radiograph of the wrists and hands
of a monkey 3 mo after immunization with type
II collagen . There is soft tissue swelling and
marked destructive changes in both wrists . Sev-
eral metacarpophalangeal and interphalangeal
joints are narrowed with erosions .
refused to bear weight on their legs and sat in the back corner of their cages . This
resulted in contracture of the flexor tendons of the legs which did not resolve .
Discomfort was judged to be sufficiently severe enough to require therapy and
aspirin was given by gavage in a dosage of 25 mg/kg/d. In addition, injectable anal-
gesics (butorphanol, nalbuphine)were used on some occasions . Most of the monkeys
improved after 100 d. There was increase in body weight, mobility, and a return
of normal disposition . The most severely affected monkey, however, had to be eu-
thanized at day 108 because of severe inanition .
Pathologic Changes .
￿
At autopsy, the connective tissue of the arthritic knees, wrists,
metacarpophalangeal, and interphalangeal joints were tightly adhered to the joint
capsules . The cartilage surfaces were rough and eroded (Fig . 4) . In contrast, both
the unimmunized and type I collagen-immunized monkeyshad freely movable joints
with smooth cartilage surfaces . By histologic examination, synovial hypertrophy was
detected along with cartilage destruction . Some neutrophils were seen on surfaces
ofthe eroded articular cartilage . The synovium washypertrophic andthere waslym-
phocyte infiltration around blood vessels . (Fig . 5) . In some areas subchondral bone
was destroyed by granulation tissue . A mild proteinaceous exudate including a few
neutrophils was seen in the joint lumen.
Immune Response to Collagen .
￿
All ofthemonkeys immunized with type II collagen
developed high levels of circulating antibody specific for the immunizing antigen
FIGURE 3 .
￿
Photograph of the wrist of a monkey immunized 3 mo previously with type II col-
lagen showing restricted flexion (left) the wrist ofa controlmonkey (right) is shown for comparison.780
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FIGURE 4 .
￿
Cartilage surfaceof knee joints from type II collagen immunized (right) andcontrol
animal (left) at autopsy. Thecontrol joint has asmooth cartilage surface in contrast to the rough
and eroded cartilage surface of the arthritis joint .
(Table I) . When antibody levels to fragments of collagen were measured, there was
substantial heterogeneity in the response (Table I) . However, all monkeys responded
strongly to cyanogen bromide peptide 11, which has previously been shown to con-
tain an epitope arthritogenic for DBA/1 mice (6) . This was in fact the only peptide
with which all immune sera reacted strongly.
Discussion
Cathcart and colleagues (5) have shown that squirrel monkeys will also develop
arthritis after immunization with type II collagen, and we have now shown that a
primate even more closely related to man will also develop arthritis after immuniza-
tion with type II collagen . In addition, the arthritis we observed was characterized
by cartilage and bone erosions quite similar to those seen in human rheumatoid
arthritis .
The disease we observed differed in some respects from that reported in squirrel
monkeys . Its onset was insidious, with constitutional symptoms appearing first . Only
later did joint inflammation become clearly evident . In some individual monkeys
the disease was relapsing or could at least be induced to flare by reinjecting the an-
imal with type II collagen . In squirrel monkeys the disease was abrupt in onset with
FIGURE 5 .
￿
Histopathology ofamiddle
finger from a monkey 4mo after im-
munization (x 320) . There is synovial
hypertrophy with marked infiltration
of the subsynovial tissue with inflam-
matory cells . Thecartilage appears ir-
regular and marginal erosion is pres-
ent .On higher power examination most
of the cells appear to be lymphocytes
but many neutrophils were also seen .YOO ET AL.
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TABLE I
Antibody Titer to Type II Collagen Measured by ELISA
* Animals were immunized with native bovine type II Collagen.
1 Animals were immunized with native bovine type I collagen.
very rapid progression. In both squirrel monkeys and our animals severe inanition
occurred. The basis for this is not certain. In one case it was sufficiently severe to
necessitate termination of the experiment with euthanasia of the monkey. This ina-
nition may have been in part due to the inability to grasp food but this seems an
inadequate explanation. At autopsy, no gastrointestinal lesion was identified. The
monkeys were, however, noted to have lesions of the middle and inner ear. Such le-
sionshave previously been reported in rodents (9) and may have contributed to nausea,
vertigo, and anorexia in the monkey.
Immune responses to collagens were elicited in all immunized monkeys. The an-
tibody level to type II collagen fragments were heterogeneous; however, all of the
antisera responded strongly to CB-peptide 11 whichcontains an epitope arthrogenic
for DBA/1 mice (6). Though ourdata suggest the CB-11 peptide could be an impor-
tant arthrogenic epitope in monkeys, further experiments usingindividual CB pep-
tide fragments as immunizing antigens are needed to clarify this point.
Summary
Immunization of two cynomolugus and three rhesus monkeys with purified type
II collagen resulted in the development of polyarthritis. Arthritis first became clini-
TABLE II
Antibody Against Cyanogen Bromide Peptides of Type II Collagen
2 mo after Immunization
* Cyanogen bromide peptides were obtained by cleaving purified chick type II
Collagen with cyanogen bromide (CB).
t*BIn, animal immunized with native bovine type I Collagen; BIIn, animals im-
munized with native bovine type II collagen.
Group
Animal
number Dilution CB8*
Absorbance
CB10
at 490 nm
CB11 CB12
Control 416 1 :75 0.066 0.106 0.101 0 .119
BIn 88 1 :500 0.045 0.051 0.068 0 .091
BIIn 411 1 :500 0.081 0.358 0.407 0 .117
BIIn 419 1 :500 0.091 0.130 0.351 0 .850
BIIn 1121 1 :400 0.180 0.297 0.389 0.115
Monkey
number Test antigen
Absorption
Sera
1/100
BIIn
at 490 nm at
dilution of:
1/500
BIn
416 Control 0.048 -
88 Type 1* 0.028 0.33
419 Type 111 1 .500 -
411 Type 111 0.591 -
1120 Type 111 0.522 -782
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cally apparent 7 wk after primary immunization and persisted for 16 mo. Radio-
logic examination of the limbs demonstrated soft tissue swelling with severe joint
destruction including loss of cartilage and bone. Involved joints eventually became
ankylosed with permanent loss of some motion. All of the monkeys developed a re-
sponse to the immunizing collagen as determinedby ELISA ofserum for antibodies.
Arthritis was associated with weight loss and constitutional symptoms, including
lethargy and refusal to eat. One monkey became so debilitated that it was necessary
to euthanize it. Histologic examination of the joints showed synovial hypertrophy
with pannus formation. A control monkey immunized with type I collagen suffered
no apparent ill effects.
Receivedfor publication 14 March 1988 and in revisedform 16 May 1988.
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